Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2026-01-16 @ 6:29 AM
Study NCT ID:
NCT06176261
Status:
RECRUITING
Last Update Posted:
2025-07-30
First Post:
2023-12-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Sponsor:
Sarah Sammons, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
23-533
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |